Double Express Diffuse Large B-cell Lymphoma
2 clinical trials · Condition
◉ Watch Double Express Diffuse Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL (NCT06890585) | Li Zhiming | 2025-06-01 |
| A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy (NCT05527912) | Sun Yat-sen University | 2023-02-24 |
Track Double Express Diffuse Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.